FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Incorporated in 2007, Eris Lifesciences Limited is a full integrated Pharmaceutical company. The company is a leading manufacturer of chronic category and acute category. The company is second fastest growing in Chronic therapy segment. Company is focused on formulations market of cardiovascular; anti-diabetes; vitamins; gastroenterology and gynecology.
July 4th, 2019:Eris Lifesciences Limited (BSE:540596 | NSE:ERIS) board has approved a proposal for purchase of up to 17.39 lakh(Seventeen lakhs and thirty nine thousand) shares at Rs 575 (Five hundred seventy five) per share, aggregating Rs 100 Cr(one hundred crore) (Buyback Offer Size) that is 1.26% of total paid- up equity capital of the Company.
Below is the complete details about Eris Lifesciences Limited Buyback. Record date, buyback open and close dates are announce in below section.
Buyback Type: | Tender Offer |
Buyback Offer Amount: | Rs 100 Cr |
Buyback Number of Shares: | 17.39 Lakhs |
Buyback Price: | Rs 575 |
Buyback Offer Size (In %): | 1.26% |
Total Share Capital: | Rs 6,822.36 Cr |
Face Value: | 1 Per Equity Share |
Can I Invest today to participate in Eris Lifesciences Limited buyback offer? No
We advocate honest for Eris Lifesciences buyback as official acceptance ratio for the retail investors are going to be between 15 to 20% (Fifteen to Twenty percent) and actual acceptance ration is going to be thirty to sixty percent (30% to 60%). We tend to rate Eris Lifesciences buyback as 3.5/5 (Average).
Making a resonable amount of profit is possible in Eris Lifesciences buyback for a new retail investor. Buyback price is up by 15% from current market price.
As per March 2019 shareholding approx 15,00,000 shares are hold by retail investors, number of shares blocked for retail share holders are 2.60 lakhs. So in that approx buyback acceptance ration is going to above 15%.
In this section we have covered all important dates related to Eris Lifesciences Limited Buyback. Dates are updated as they are announced. The most noted dates are record date and buyback open and close dates, which one should use to participate in buyback.
Buyback Activity | Date |
---|---|
Board Meeting for Buyback proposal | 3rd Jul 2019 |
Buyback Approval date | 3rd Jul 2019 |
Public Announcement of Buyback | 4th Jul 2019 |
Record Date | 15th Jul 2019 |
Buyback opens on/Buyback Opening Date | 1st Jan 2020 |
Buyback closes on/Buyback Closing Date | 14th Jan 2020 |
Cut-off date to receive completed tender forms by Registrar | 22nd Jan 2020 |
Cut-off date for verification by the Registrar | 22nd Jan 2020 |
Cut-off date to inform Stock Exchange on acceptance or non-acceptance
of tendered Equity Shares by Registrar |
22nd Jan 2020 |
Last date of settlement of bids on the stock exchange | 23rd Jan 2020 |
Last date to return unaccepted shares by Registrar | 23rd Jan 2020 |
Last date of extinguishment of Equity Shares | 30th Jan 2020 |
Stock Holding table gives a clear picture on retail investor holdings of Eris Lifesciences Limited shares which helps investor to decide on participating in buyback offer. The less number of retail holdings means higher chance of acceptance in buyback under retail category which is equal to higher profit.
Holding Type | In % |
---|---|
Promoter-Foreign | 0.0% |
Promoter-Indian | 56.10% |
Non-Promoter-Institutions | 19.79% |
Non-Promoter-Non-Institutions | 24.11% |
Eris Lifesciences Limited Draft Letter of Offer >>Document
Eris Lifesciences Limited Letter of Offer >>Document
Eris Lifesciences Limited Post Buyback Public Announcement >>Document
Category | Entitlement Ratio of Buyback Per Equity Shares | Entitlement Ratio of Buyback in % |
---|---|---|
Reserved Category | 50 Equity Share out of every 231 fully paid-up Equity Share held on the Record Date. | 21.65 |
General Category | 5 Equity Share out of every 461 fully paid-up Equity Share held on the Record Date. | 1.08% |
For Eris Lifesciences Limited Buyback Offer, Report updated by the manager of buyback -
In general category - response received 504.57%, No. of Equity Shares reserved in Buyback was 1478260 where valid bid received for retail category was 7458837 which is 504.57% oversubscribed.
In Reserved category for Small Shareholders (Retail) - response received only 160.71%, No. of Equity Shares reserved in Buyback was 260870 where valid bid received for retail category was 419246 which is 160.71%. Final Acceptance Ratio for Retail Investors was 20%.
The table below will give you a complete dashboard view for all open buyback offer in current market.
Company Name | Buyback Type | Offer Amount | Buyback Price | CMP | Record Date | Buyback Open Date | Buyback End Date |
---|---|---|---|---|---|---|---|
Tanla Platforms Ltd | Tender Offer | Rs 170 Cr | 1200 | 844.55 (-1.33%) | 25-10-2022 | TBD | TBD | Garware Technical Fibres Ltd | Tender Offer | Rs 90 Cr | 3750 | 4-11-2022 | TBD | TBD | Orbit Exports Limited | Tender Offer | Rs 10 Cr | 245 | 151.90 (-0.07%) | 18-11-2022 | TBD | TBD | KRBL Limited | Tender Offer | ₹325.00Cr | 500 | 289.75 (0.77%) | 25-08-2023 | TBD | TBD | Shervani Industrial Syndicate Limited | Tender Offer | ₹6.83Cr | 510 | 543.60 (1.91%) | 07-03-2024 | 14-03-2024 | 20-03-2024 | Dwarikesh Sugar Industries Limited | Tender Offer | ₹31.50Cr | 105 | 80.37 (0.19%) | 20-03-2024 | TBD | TBD | Garware Technical Fibres Limited | Tender Offer | ₹199.50Cr | 3800 | 3201.80 (-1.15%) | 26-03-2024 | TBD | TBD |
Detail Article on Benefit from buyback offer >> Read
Eris Lifesciences Limited Buyback Important dates - Record Date,Buyback Start and End date. Buyback Details - Buyback Price, Buyback Offer Size, Buyback Number of Shares, Retail Investors limit. What is the record date for Eris Lifesciences Limited ? How can I apply in Eris Lifesciences Limited Buyback offer?Last Updated on 2020-01-29T00:12:29+00:00
Kindly update the site as Buyback of moil has started & of eris is going to be open very soon. NIIT technology buyback ia also declared.
Regards